MGMT and glioblastoma: Some investigators had suggested that the epigenetic silencing of a DNA repair enzyme named O-6-methylguanine-DNA methyltransferase (MGMT) by promoter methylation was associated with good prognosis for patients with glioblastoma treated with alkylating agents such as TMZ [8, 9].